Results from the US industry-wide phosgene surveillance: The diller registry

Journal of Occupational and Environmental Medicine

Volumn 53, Issue 3, 2011, Pages 239-244

  Collins, James J ^a   Molenaar, Donald M ^b   Bowler, Larry O ^c   Harbourt, Tom J ^d   Carson, Michael ^a   Avashia, Bipin ^e   Calhoun, Teresa ^e   Vitrano, Craig ^f   Ameis, Paul ^g   Chalfant, Richard ^h   Howard, Pete ⁱ  

^a DOW CHEMICAL COMPANY   (United States)

^b BAYER CORPORATION   (United States)

^c SABIC INNOVATIVE PLASTICS   (United States)

^d Huntsman Polyurethanes   (United States)

^e BAYER CROPSCIENCE   (United States)

^f Occupational Physician   (United States)

^g VanDeMark   (United States)

^h DUPONT COMPANY   (United States)

ⁱ LANXESS DEUTSCHLAND GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSGENE;

ADULT; ANXIETY; ARTICLE; BIOSURVEILLANCE; CHEMICAL INDUSTRY; CHEST TIGHTNESS; CLINICAL FEATURE; CONTROLLED STUDY; COUGHING; DISEASE REGISTRY; DYSPNEA; EYE IRRITATION; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; NOSE IRRITATION; OCCUPATIONAL EXPOSURE; TASTE DISORDER; THORAX PAIN; THROAT IRRITATION; UNITED STATES;

EID: 79953035262     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/JOM.0b013e31820c90cf     Document Type: Article

References (24)

1. International Program on Chemical Safety. Environmental Health Criteria 193: Phosgene. Geneva, Switzerland: International Program on Chemical Safety; 1997.
2. National Institute for Occupational Safety and Health. Criteria for a Rec-ommend Standard: Occupational Exposure to Phosgene. HEW Publication No. (NIOSH) 76-137. Washington, DC: National Institute for Occupational Safety and Health; 1976.
3. Sciuto AM, Hurt HH. Therapeutic treatments for phosgene-induced lung injury. Inhal Toxicol. 2004;16:565-580. (Pubitemid 38923919)
4. National Institute for Occupational Safety and Health. NIOSHPocket Guide to Chemical Hazards. DHHS (NIOSH) Publication No. 2005-149. Third printing ed. Washington, DC: Department ofHealth and Human Services; 2007.
5. American Conference of Governmental Industrial Hygienists. 2010 Guide to Occupational Exposure Values. Cincinnati, OH: American Conference of Governmental Industrial Hygienists; 2010.
6. Borak J, Diller WF. Phosgene exposures: mechanisms ofinjury and treatment strategies. J Occup Environ Med. 2001;43:110-119. (Pubitemid 32175109)
7. Pauluhn J, Carson A, Costa DL, et al. Workshop summary: phosgene in-duced pulmonary toxicity revisited: appraisal of early and late markers of pulmonary injury from animal models with emphasis on human significance. Inhal Toxicol. 2007;19:789-810. (Pubitemid 47237752)
8. Diller WF. Pathogenesis of phosgenepoisoning. Toxicol Ind Health. 1985;1: 7-15.
9. Pauluhn J. Acute nose-only exposure ofrats to phosgene. Part I: concentra-tion x time dependence of LC50s, nonlethal-threshold concentrations, and analysis ofbreathing patterns. Inhal Toxicol. 2006;18:423-435.
10. Pauluhn J. Acute nose-only exposure ofrats to phosgene. Part II. Concen-tration x time dependence of changes in bronchoalveolar lavage during a follow-up period of 3 months. Inhal Toxicol. 2006;18:595-607. (Pubitemid 44178416)
11. Pauluhn J. Acute head-only exposure of dogs to phosgene. Part III. Compar-ison of indicators of lung injury in dogs and rats. Inhal Toxicol. 2006;18: 609-621. (Pubitemid 44178417)
12. Henschler D. Gesundsheitschadliche Arbeitstoffe, Toxikologisch- Arbeitmedizinische Bergrundung von MAK-Werten, Loseblattsamm-lung, Phosgen, 1. Weinheim, Germany: Lieferung 1972, VCH-Verkagsgesellschaft; 1972.
13. International Program on Chemical Safety. Phosgene: Health and Safety Guide 106. Geneva, Switzerland: International Program onChemical Safety; 1998.
14. Diller WF. Late sequelae after phosgene poisoning: a literature review. Toxicol Ind Health. 1985;1:129-136. (Pubitemid 16020416)
15. Cucinell SA, Arsenal EA. Review of the toxicity oflong-term phosgene exposure. Arch Environ Health. 1974;28:272-275.
16. Russell D, Blaine PG, Rice P. Clinical management ofcausalities exposedto lung damaging agents: a critical review. Emerg Med J. 2006;23:421-424. (Pubitemid 44376955)
17. Galdston M, Leuetscher JA, Longcope WT, et al. Residual effects ofphos-gene poisoning in human subjects-II: after chronic exposure. J Clin Invest. 1947;26:169-181.
18. Ott MG, Diller WF, Jolly AT. Respiratory effects oftoluene di-isocyanate in the workplace: a discussion of exposure-response relationship. Crit Rev Toxicol. 2003;33:1-59. (Pubitemid 36187393)
19. Dunlap KL. Phosgene. Kirk-Othmer Encyclopedia of Chemical Technology. New York, NY: John Wiley& Sons Inc; 2001.
20. Venables KM, Farrer N, Sharp L, Graneek BJ, Newman-Taylor AJ. Respiratory symptoms questionnaire for asthma epidemiology: validity and reproducibi-lity. Thorax. 1993;48:214-219. (Pubitemid 23090239)
21. Guyatt GH, Berman LB, Townsend M, Puglsey SO, Chambers LW. A mea-sure of quality of life for clinical trials in chronic lung disease. Thorax. 1987;42:773-778. (Pubitemid 17142007)
22. SAS. SASSystem (for Windows). Release 8.0. Cary NC: SAS Institute; 2003.
23. Schulte PA, Trout D, Zumwalde RD, et al. Options for occupational health surveillance ofworkers potentially exposed to engineered nanoparticles: state ofthe science. J Occup Environ Med. 2008;50:517-526. (Pubitemid 351677634)
24. Halperin WE. The role ofsurveillance in the hierarchy ofprevention. Am J Ind Med. 1996;29:321-323.